A new analysis of drug trials used to approve medicines in the United States shows how far modern medicine still has to go to ...

Fueled by advances in biomarkers, brain mapping, and AI, investment in neuro and CNS innovation shows no signs of slowing, ...

Backed with $82 million and led by two of BioMarin’s former executives, Mendra plans to acquire rare disease assets and use ...

Investors in biotech companies approach their investments with the mindset of praying or scratching a lottery ticket because the success rate of new drug development is extremely low, and the costs ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...

Forbes contributors publish independent expert analyses and insights. Gil Press writes about technology, entrepreneurs and innovation. Will AI transform the typical trials and tribulations of drug ...

In Darwinian terms, survival isn’t a matter of being the biggest, the fastest, or the strongest of the species, but instead ...

President Kim Kyung-ah of Samsung Epis Holdings held a press briefing on the 14th at the JP Morgan Healthcare Conference in ...

Cambridge’s Kendall Square bills itself as “the most innovative square mile on the planet” — but it’s possible that less of that innovation is happening in Cambridge as life science firms outsource ...

FORT WORTH, Texas, Dec. 17, 2025 /PRNewswire/ -- NanOlogy, LLC, a clinical-stage oncology company, today announced the appointment of David Arthur as Chief Executive Officer. This appointment reflects ...